There was an error in the first sentence of the Funding Statement. The first sentence of the Funding Statement should read: "The funders of Sividion Diagnostics, Cologne, Germany conducted the Endopredict assay on all 34 tissue samples in a blinded way upon request of the authors."
Citation: Varga Z, Sinn P, Fritzsche F, von Hochstetter A, Noske A, Schraml P, et al. (2013) Correction: Comparison of EndoPredict and Oncotype DX Test Results in Hormone Receptor Positive Invasive Breast Cancer. PLoS ONE 8(10): 10.1371/annotation/f715f38e-7aee-4d2b-8bbf-da0411dc6ef3. https://doi.org/10.1371/annotation/f715f38e-7aee-4d2b-8bbf-da0411dc6ef3
Published: October 17, 2013
Copyright: © 2013 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Competing interests: No competing interests declared.